ACEi and ARBS in Hypertension and Heart Failure /
This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients...
Sábháilte in:
| Údar corparáideach: | |
|---|---|
| Rannpháirtithe: | |
| Formáid: | Ríomhleabhar |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Sraith: | Current Cardiovascular Therapy ;
5 |
| Ábhair: | |
| Rochtain ar líne: | Click here to view the full text content |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Clár na nÁbhar:
- Pathogenetic mechanisms of RAS involvement in cardiovascular diseases
- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.- Renin angiotensin system antagonism in heart failure
- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients
- Target organ damage and RAS blockade.